-
Signature
-
/s/ Jason Cohen, Attorney-in-fact
-
Issuer symbol
-
INFA
-
Transactions as of
-
07 Sep 2023
-
Net transactions value
-
-$3,022,219
-
Form type
-
4
-
Filing time
-
08 Sep 2023, 18:33:50 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INFA |
Class A Common Stock |
Options Exercise |
$1,245,675 |
+143,181 |
+9% |
$8.70 |
1,734,315 |
07 Sep 2023 |
Direct |
F1 |
| transaction |
INFA |
Class A Common Stock |
Options Exercise |
$1,318,180 |
+131,818 |
+7.6% |
$10.00 |
1,866,133 |
07 Sep 2023 |
Direct |
F1 |
| transaction |
INFA |
Class A Common Stock |
Sale |
$4,513,773 |
-212,633 |
-11% |
$21.23 |
1,653,500 |
07 Sep 2023 |
Direct |
F1, F2, F3, F4 |
| transaction |
INFA |
Class A Common Stock |
Sale |
$1,072,300 |
-50,000 |
-3% |
$21.45 |
1,603,500 |
08 Sep 2023 |
Direct |
F1, F2, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INFA |
Stock Option (right to buy) |
Options Exercise |
$0 |
-143,181 |
-100% |
$0.000000* |
0 |
07 Sep 2023 |
Class A Common Stock |
143,181 |
$8.70 |
Direct |
F6 |
| transaction |
INFA |
Stock Option (right to buy) |
Options Exercise |
$0 |
-131,818 |
-100% |
$0.000000* |
0 |
07 Sep 2023 |
Class A Common Stock |
131,818 |
$10.00 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: